Diabetes and vascular disease: Common links in the emerging epidemic of coronary artery disease

American Journal of Cardiology

Volumn 91, Issue 1, 2003, Pages 68-71

  Deedwania, Prakash C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANTILIPEMIC AGENT; BLOOD CLOTTING FACTOR 10; COPPER ZINC SUPEROXIDE DISMUTASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADRENERGIC SYSTEM; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; EDITORIAL; ENVIRONMENTAL FACTOR; EPIDEMIC; HEMODYNAMICS; HEREDITY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; METABOLIC DISORDER; MORBIDITY; MORTALITY; OBESITY; OXIDATIVE STRESS; PREMENOPAUSE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SMOKING; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; WORLD HEALTH ORGANIZATION;

EID: 0037223536     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03000-X     Document Type: Note

References (33)

1. Donnelly R., Emslie-Smith A.M., Gardner I.D., Morris A.D. ABC of arterial and venous disease. Vascular complications of diabetes. BMJ. 320:2000;1062-1066.
2. Ray N.F., Thamer M., Gardner E., Chan J. Economic consequences of diabetes mellitus in the U. S. in 1997. Diabetes Care. 21:1998;296-309.
3. Wilson P, Kannel W. Epidemiology of hyperglycemia and atherosclerosis. In: Ruderman N, Brownlee M, Williamson JR, eds. Hyperglycemia, Diabetes, and Vascular Disease. London: Oxford University Press, 1992:21-29.
4. Stamler J, Vaccaro O, Neaton JD, Wentworth D, Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 1993;16:434-444.
5. Haffner S.M., Lehto S., Ronnemaa T., Pyroala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339:1998;229-234.
6. Ravikumar R., Depa R., Shanthirani C.S., Mohan V. Comprison of carotid intima-media thickness, arterial stiffness and brachial artery flow mediated dilatation in diabetic and non-diabetic subjects (The Chennai Urban Population Study [CUPS-9]. Am J Cardiol. 90:2002;702-707.
7. Deedwania P.C. The deadly quartet revised. Am J Med. 105:1998;1S-3S.
8. Fagan T.C., Deedwania P.C. The cardiovascular dysmetabolic syndrome. Am J Med. 105:1998;77S-82S.
9. Pyörälä M., Miettinin H., Laakso M., Pyörälä K. Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men. The 22-year follow-up results of the Helsinki Policemen Study. Circulation. 98:1998;398-404.
10. NCEP Expert Panel. Executive summary of the third report on the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001:285:2486-2497.
11. Guerci B., Böhme P., Kearney-Schwartz A., Zannad F., Drouin P. endothelial dysfunction and type 2 diabetes. Diabetes Metab. 27:2001;436-447.
12. Nitenberg A., Paycha F., Ledoux S., Sachs R., Attali J.R., Valensi P. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation. 97:1998;736-743.
13. Vehkavaara S., Seppälä-Lindroos A., Westerbacka J., Groop P.H., Yki-Järvinen H. In vivo endothelial function characterizes patients with impaired fasting glucose. Diabetes Care. 22:1999;2055-2060.
14. Tomiyama H., Kimura Y., Okazaki R., Kushiro T., Abe M., Kuwabara Y., Yoshida H., Kuwate S., Konouchi T., Doba N. Close relationship of abnormal glucose tolerance with endothelial dysfunction in hypertension. Hypertension. 36:2000;245-249.
15. Avogaro A., Pairulli F., Valerio A., Miola M., Calveri M., Pavan P., Vicini P., Cobelli C., Tiengo A., Calo L., DelPrato S. Forearm nitric oxide balance, vascular relaxation, and glucose metabolish in NIDDM patients. Diabetes. 46:1997;1040-1046.
16. Hogikyan R.V., Galecki A.T., Pitt B., Halter J.B., Greene D.A., Supiano M.K. Specific impairment of endothelium-dependent vasodilation in subjects with type 2 diabetes. J Clin Endocrinol Metab. 83:1998;1946-1952.
17. Williams S.B., Cusco J.A., Roddy M.A., Johnstone M.T., Creager M.A. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 27:1996;567-574.
18. Enderle M.D., Benda N., Schmuelling R.M., Haering H.U., Pfohl M. Preserved endothelial function in IDDM patients, but not in NIDDM patients, compared with healthy subjects. Diabetes Care. 21:1998;271-277.
19. Kawano H., Motoyama T., Hirashima O., Hirai N., Miyao Y., Sakamoto T., Kugiyama K., Ogawa H., Yasue H. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol. 34:1999;146-154.
20. Title L.M., Cummings P.M., Giddens K., Nassar B.A. Oral glucose loading acutely attenuates endothelium-dependent vasodilation in healthy adults without diabetes an effect prevented by vitamins C and E. J Am Coll Cardiol. 36:2000;2185-2191.
21. Tesfamariam B., Brown M.L., Cohen R.A. Elevated glucose impairs endothelium-dependent relaxtion by activating protein kinase C. J Clin Invest. 87:1991;1643-1648.
22. Park J.Y., Takahara N., Gabriele A., Chou E., Naruse K., Suzuma K., Yamauchi T., Ha S.W., Meier M., Rhodes C.J., King G.L. Induction of endothelin-1 expression by glucose. An effect on protein kinase C activation. Diabetes. 49:2000;1239-1248.
23. Williams B. Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues. Diabetologia. 40:1997;S118-S120.
24. Bucala R., Tracey K.J., Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest. 87:1991;432-438.
25. Tesfamariam B. Free radicals in diabetic endothelial cell dysfunction. Free Radic Biol Med. 16:1994;383-391.
26. Tesfamariam B., Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol. 263:1992;. H321-326.
27. Laight D.W., Carrier M.J., Anggard E.E. Endothelial cell dysfunction and the pathogenesis of diabetic macroangiopathy. Diabetes Metab Res Rev. 15:1999;274-282.
28. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron AO. Insulin-mediated muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release J Clin Invest 1994;94: 1172-1179.
29. Steinberg H.O., Chaker H., Learning A., Johnson A., Brechtel G., Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction. Implication for the syndrome of insulin resistance. J Clin Invest. 97:1996;2601-2610.
30. Ferri C., Bellini C., Desideri G., Francesco L.D., Baldoncini R., Santucci N., DeMattia G. Plasma endothelin-1 levels in obese hypertensive and normotensive men. Diabetes. 44:1995;431-436.
31. Mokadad A.H., Ford E.S., Bowman B.A., Nelson D.E., Engelgau M.M., Vinicor F., Marks J.S. Diabetes trends in the US.: 1990-1998. Diabetes Care. 23:2000;1278-1283.
32. Mohan V., Deepa R., Shanthirani C.S., Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India - The Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol. 38:2001;682-687.
33. Deedwania P.C. Diabetes is the most prevalent risk factor for premature vascular disease in migrant Asian Indians (abstr). J Am Coll Cardiol. 39:2002;252A.